Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

February 16, 2021Views & Reviews

The 5 Pillars in Tourette Syndrome Deep Brain Stimulation Patient Selection: Present and Future

Davide Martino, Wissam Deeb, View ORCID ProfileJoohi Jimenez-Shahed, Irene Malaty, Tamara M. Pringsheim, Alfonso Fasano, Christos Ganos, Winifred Wu, Michael S. Okun
First published February 16, 2021, DOI: https://doi.org/10.1212/WNL.0000000000011704
Davide Martino
1Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, AB, Canada;
2Hotchkiss Brain Institute, University of Calgary, AB, Canada;
3Alberta Children's Hospital Research Institute, University of Calgary, AB, Canada;
4Mathison Centre for Mental Health Research and Education, , AB, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wissam Deeb
5UMass Memorial Medical Center and UMass Medical School, , MA, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joohi Jimenez-Shahed
6Department of Neurology, Icahn School of Medicine at Mount Sinai, , NY, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joohi Jimenez-Shahed
Irene Malaty
7Dept. of Neurology, Norman Fixel Institute for Neurological Diseases, University of Florida Health, , FL, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tamara M. Pringsheim
1Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, AB, Canada;
2Hotchkiss Brain Institute, University of Calgary, AB, Canada;
4Mathison Centre for Mental Health Research and Education, , AB, Canada;
8Department of Psychiatry, Pediatrics and Community Health Sciences, University of Calgary, AB, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfonso Fasano
9Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, Ontario, Canada; Division of Neurology, University of Toronto, , Ontario, Canada;
10Krembil Brain Institute, , Ontario, Canada;
11CenteR for Advancing Neurotechnological Innovation to Application (CRANIA), , ON, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christos Ganos
12Movement Disorders and Neuromodulation Unit, Charité, University Medicine Berlin, Department of Neurology, , Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Winifred Wu
13Strategic Regulatory Partners, .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael S. Okun
7Dept. of Neurology, Norman Fixel Institute for Neurological Diseases, University of Florida Health, , FL, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
The 5 Pillars in Tourette Syndrome Deep Brain Stimulation Patient Selection: Present and Future
Davide Martino, Wissam Deeb, Joohi Jimenez-Shahed, Irene Malaty, Tamara M. Pringsheim, Alfonso Fasano, Christos Ganos, Winifred Wu, Michael S. Okun
Neurology Feb 2021, 10.1212/WNL.0000000000011704; DOI: 10.1212/WNL.0000000000011704

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
23

Share

  • Article
  • Info & Disclosures
Loading

Abstract

The selection of Tourette syndrome (TS) patients for deep brain stimulation (DBS) surgery rests on five fundamental pillars. However, the operationalization of the multidisciplinary screening process to evaluate these pillars remains highly diverse especially across sites. High tic severity and tic-related impact on quality of life (first two pillars) require confirmation from objective, validated measures, but 'malignant' features of TS should per se suffice to fulfill this pillar. Failure of behavioral and pharmacologic therapies (third pillar) should be assessed taking into account refractoriness through objective and subjective measures supporting lack of efficacy of all interventions of proven efficacy, as well as true lack of tolerability, adherence or access. Educational interventions and use of remote delivery formats (for behavioral therapies) play a role in preventing misjudgment of treatment failure. Stability of comorbid psychiatric disorders for 6 months (fourth pillar) is needed to confirm the predominant impact of tics on quality of life, prevent pseudo-refractoriness, and to maximize the future DBS response. The 18 years age limit (fifth pillar) is currently under reappraisal, considering the potential impact of severe tics in adolescence and the predictive effect of tic severity in childhood on tic severity when transitioning into adulthood. Future advances should aim at a consensus-based definition of failure of specific, non-invasive treatment strategies for tics and of the minimum clinical observation period before considering DBS treatment, the stability of behavioral comorbidities, and the use of a prospective international registry data to identify predictors of positive response to DBS, especially in younger patients.

  • Received September 5, 2020.
  • Accepted in final form January 14, 2021.
  • © 2021 American Academy of Neurology

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

  • Decision analysis
  • Tourette syndrome
  • Harm/ risk (analysis)
  • Surgery/Stimulation
  • Tics

Alert Me

  • Alert me when eletters are published
Neurology: 96 (9)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise